ARTV

Artiva Biotherapeutics
ARTV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$67.17M
EV
$-61.97M
Shares Outstanding
24.43M
Beta
-

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$15.40
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Artiva Biotherapeutics, Inc.

gainify
ARTV

Artiva Biotherapeutics, Inc.

ARTV

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate is AB-101, an off-the-shelf NK cell t...

Sector

Industry

CEO

Aslan, Fred

Employees

105

IPO Date

Headquarters

5505 Morehouse Drive, Suite 100, San Diego, California, 92121, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.